Yes. KALA BIO was formerly owned by 1 private investor.
KALA BIO is headquartered in Arlington, Massachusetts.
KALA BIO disclosed revenue of 4M USD for 2022 and 11M USD for 2021.
KALA BIO has 38 employees.
KALA BIO is a life science company.
KALA BIO was founded in 2009.
1167 Massachusetts Avenue,
Arlington, Massachusetts
02476
United States,
(781) 996-5252
www.kalarx.com
KALA BIO is a clinical-stage pharmaceutical company focused on innovative nanoparticle-based treatments for ocular diseases affecting both the front and back of the eye. KALA BIO was founded in 2009 and is based in Arlington, Massachusetts.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | 1 | - | - | - | - | 1 |
| vol | $16M | $16M | ||||||
| Sell (0.2/yr) | # | - | - | 1 | - | - | - | 1 |
| vol | $60M | $60M | ||||||
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
